Showing results (181-190 of 188) with videos related to
Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 188 results.
Frontiers in Neurology|August 28, 2020
Harnessing Real-World Data to Inform Decision-Making: Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS PATHS)Ellen M Mowry, Robert A Bermel, James R Williams, et al.Annals of Neurology|February 5, 1998
Magnetic resonance studies of intramuscular interferon beta-1a for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research GroupJ H Simon, L D Jacobs, M Campion, et al.Neurology|August 1, 1997
Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)R A Rudick, D E Goodkin, L D Jacobs, et al.Annals of Neurology|March 1, 1996
Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)L D Jacobs, D L Cookfair, R A Rudick, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|February 13, 1999
Comparing the ability of various compositive outcomes to discriminate treatment effects in MS clinical trials. The Multiple Sclerosis Collaborative Research Group (MSCRG)D E Goodkin, R L Priore, K E Wende, et al.Journal of Neuroimmunology|June 23, 1999
Cerebrospinal fluid abnormalities in a phase III trial of Avonex (IFNbeta-1a) for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research GroupR A Rudick, D L Cookfair, N A Simonian, et al.Neurology|May 30, 2014
Defining the clinical course of multiple sclerosis: the 2013 revisionsFred D Lublin, Stephen C Reingold, Jeffrey A Cohen, et al.NPJ Digital Medicine|December 17, 2019
Quantifying neurologic disease using biosensor measurements in-clinic and in free-living settings in multiple sclerosisTanuja Chitnis, Bonnie I Glanz, Cindy Gonzalez, et al.Pageof 19